Why the study?
Does the Orthocor II antitachycardia pacemaker effectively terminate recurrent tachyarrhythmias in drug-refractory patients?
Does the Orthocor II antitachycardia pacemaker effectively terminate recurrent tachyarrhythmias in drug-refractory patients?
The Orthocor II antitachycardia pacemaker provided effective termination of recurrent, drug-refractory SVT in a small case series, though adjunctive antiarrhythmic therapy was frequently required.
No takes yet. Share an insight, caveat, or question.
May support antitachycardia pacing for refractory SVT; leaves open its role in VT and need for prospective trials.
Occhetta et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: